CGON
CG Oncology Inc.NASDAQStock$78.63-0.35 (-0.44%)Mkt Cap 6.9BP/E —Div Yield —Beta 0.23Vol 172.4KAvg Vol 788.7K
52W$26.48
$80.68
ETFs That Hold CGON (CG Oncology Inc.)
1M
+6.95%
3M
+29.47%
6M
+33.72%
YTD
+88.16%
1Y
+190.90%
3Y
+111.54%
5Y
+111.54%
ETFs That Hold CGON
CG Oncology Inc. is held by 84 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| ITDI | iShares LifePath Target Date 2065 ETF | 0.01% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.01% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 5 of 5
Frequently Asked Questions
How many ETFs hold CGON?
CG Oncology Inc. (CGON) is held by 84 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds CGON?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $11.58B in AUM holds 1.29% of its portfolio in CGON, representing $149.9M in market value.
What percentage of SBIO is CGON?
CGON makes up 3.43% of SBIO (ALPS Medical Breakthroughs ETF), making it one of the largest positions in that fund.
Is CGON in the S&P 500?
CGON is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.